全文获取类型
收费全文 | 7474篇 |
免费 | 645篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 244篇 |
妇产科学 | 200篇 |
基础医学 | 1104篇 |
口腔科学 | 99篇 |
临床医学 | 825篇 |
内科学 | 1507篇 |
皮肤病学 | 141篇 |
神经病学 | 781篇 |
特种医学 | 122篇 |
外科学 | 943篇 |
综合类 | 95篇 |
一般理论 | 4篇 |
预防医学 | 885篇 |
眼科学 | 91篇 |
药学 | 560篇 |
中国医学 | 36篇 |
肿瘤学 | 450篇 |
出版年
2023年 | 93篇 |
2022年 | 56篇 |
2021年 | 268篇 |
2020年 | 183篇 |
2019年 | 252篇 |
2018年 | 270篇 |
2017年 | 195篇 |
2016年 | 166篇 |
2015年 | 239篇 |
2014年 | 274篇 |
2013年 | 388篇 |
2012年 | 584篇 |
2011年 | 530篇 |
2010年 | 335篇 |
2009年 | 295篇 |
2008年 | 456篇 |
2007年 | 426篇 |
2006年 | 421篇 |
2005年 | 408篇 |
2004年 | 380篇 |
2003年 | 303篇 |
2002年 | 287篇 |
2001年 | 104篇 |
2000年 | 86篇 |
1999年 | 80篇 |
1998年 | 42篇 |
1997年 | 33篇 |
1996年 | 37篇 |
1995年 | 51篇 |
1994年 | 34篇 |
1993年 | 45篇 |
1992年 | 64篇 |
1991年 | 56篇 |
1990年 | 43篇 |
1989年 | 47篇 |
1988年 | 59篇 |
1987年 | 39篇 |
1986年 | 47篇 |
1985年 | 36篇 |
1984年 | 33篇 |
1983年 | 35篇 |
1982年 | 27篇 |
1981年 | 19篇 |
1980年 | 26篇 |
1979年 | 33篇 |
1978年 | 32篇 |
1976年 | 25篇 |
1974年 | 24篇 |
1973年 | 22篇 |
1972年 | 17篇 |
排序方式: 共有8141条查询结果,搜索用时 390 毫秒
1.
Alicia C. McDonald PhD MPH Jeremy Gernand PhD Nathaniel R. Geyer DrPH Hongke Wu MD MPH Yanxu Yang MPH Ming Wang PhD 《Cancer》2022,128(9):1832-1839
2.
3.
4.
Mariángeles González Fernández Elena Villamañán Inmaculada Jiménez-Nácher Francisco Moreno Chamaida Plasencia Francisco Gayá Alicia Herrero Alejandro Balsa 《Reumatología clinica》2021,17(6):335-342
ObjectiveTo assess the evolution of cost per patient/year and the cost per patient/year/drug in patients with rheumatoid arthritis (RA) receiving biological treatments. To analyze and quantify the factors influencing this evolution, such as the optimization of the biological drugs, the use of biosimilars, and official discounts and discounts obtained after negotiated procedures. In addition, to assess specific clinical parameters of disease activity in these patients.MethodsRetrospective, observational study conducted in a Spanish tertiary hospital. Adult patients diagnosed with RA under treatment from 2009 to 2017 were included.Results320, 270 and 389 patients were included in 2009, 2013 and 2017, respectively. The patient/year cost decreased from 10,789€ in 2009, 7491€ in 2013 to 7116€ in 2017. In 2017, due to the established competition, discounts of 14% and 29.5% were achieved on etanercept and its biosimilar; 11.5%, 17.8%, 17.9%, 17.3% on adalimumab, certolizumab, golimumab and tocilizumab IV respectively, and 24.6% and 43.1% on infliximab and its biosimilar. The percentage of patients optimized in 2017 was 35.2%. The annual saving in 2017 was 1,288,535€ (830,000€ due to dose optimization and/or administration regimens, 249,666€ corresponding to 7.5% of the official discount and 208,868€ after negotiated procedures).ConclusionThe annual cost per patient in RA decreased considerably due to different factors, such as discounts on the purchase of drugs due to official discounts and negotiated procedures, together with the optimization of therapies, the latter being the factor that contributed most to this decrease. 相似文献
5.
Maruyama Jessica Mayumi Santos Iná S. Munhoz Tiago Neuenfeld Matijasevich Alicia 《European child & adolescent psychiatry》2021,30(12):1939-1948
European Child & Adolescent Psychiatry - There is growing evidence that adolescent positive attributes and social aptitudes are associated with beneficial outcomes, including higher educational... 相似文献
6.
Medicine, Health Care and Philosophy - Over the last 50 years, the term professionalism has undergone a widespread expansion in its use and a semantic shift in its meaning. As a result, it... 相似文献
7.
8.
9.
Alicia Julibert Maria del Mar Bibiloni Josep A. Tur 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(9):887-905
Background and aimsThe metabolic syndrome (MetS) is a cluster of coexisting cardiovascular risk factors. The role of specific dietary fats was reemphasized by dietary recommendations. This systematic review aims to assess evidence for the effect of dietary fat intake on MetS occurrence and reversion in adults.Methods and ResultsThe MEDLINE database was used to search the existing literature. We included observational studies that analyzed dietary fat intake in adults with MetS and clinical trials that compared the effects of different dietary fat diets on MetS and/or its components. Thirty articles were selected (14 observational and 16 clinical trials), and we included information of dietary fat and fatty acids as well as MetS, body mass index, cholesterol, hypertension, and diabetes in adults. SFA intake was found to be positively associated with MetS components. Most of the observational reviewed studies found beneficial associations between MUFA and PUFA (including n-3 and n-6 subtypes) intake and MetS components. Clinical trials also supported the benefits of MUFA- or PUFA-enriched diets (including low-fat diets) in reducing MetS.ConclusionsThe effects of dietary SFAs on MetS will be influenced by other specific nutrients. Replacement of SFA by MUFA and PUFA has been associated with a decrease in MetS. Dietary recommendations should emphasize on different qualities of fat intake, not only to reduce total fat intake, to obtain health benefits in adults. 相似文献
10.